Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Cytostatic Agents"" wg kryterium: Temat


Tytuł:
Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate.
Autorzy:
Cooper E; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Oyagawa CRM; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Johnson R; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Choi PJ; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Foliaki JM; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Correia J; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand.
Schweder P; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand.
Heppner P; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand.
Mee E; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Neurosurgery, Auckland City Hospital, Private Bag 92024, Auckland, 1142, New Zealand.
Turner C; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.; Department of Anatomical Pathology, Auckland City Hospital, 2 Park Road, LabPlus, Auckland, New Zealand.
Faull R; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Denny WA; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand.
Dragunow M; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .
Jose J; Auckland Cancer Society Research Centre, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .
Park TI; Department of Pharmacology, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .; Neurosurgery Research Unit, The Centre for Brain Research, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jan 11; Vol. 22 (1), pp. 30. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Carbocyanines*
Cytostatic Agents*/pharmacology
Cytostatic Agents*/therapeutic use
Glioblastoma*/drug therapy
Glioblastoma*/metabolism
Indoles*
Piperazines*
Pyridines*
Humans ; Apoptosis ; Cell Line, Tumor ; Receptors, Tumor Necrosis Factor/physiology ; Receptors, Tumor Necrosis Factor, Type I/metabolism ; Tumor Microenvironment ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł:
The strain-dependent cytostatic activity of Lactococcus lactis on CRC cell lines is mediated through the release of arginine deiminase.
Autorzy:
Jastrząb R; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, Warsaw, 02-106, Poland.; Olimp Laboratories, Pustynia 84F, Debica, 39-200, Poland.
Tomecki R; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, Warsaw, 02-106, Poland.; Faculty of Biology, University of Warsaw, Miecznikowa 1, Warsaw, 02-089, Poland.
Jurkiewicz A; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, Warsaw, 02-106, Poland.
Graczyk D; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, Warsaw, 02-106, Poland.
Szczepankowska AK; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, Warsaw, 02-106, Poland.
Mytych J; Olimp Laboratories, Pustynia 84F, Debica, 39-200, Poland.
Wolman D; Olimp Laboratories, Pustynia 84F, Debica, 39-200, Poland.
Siedlecki P; Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, Warsaw, 02-106, Poland. .
Pokaż więcej
Źródło:
Microbial cell factories [Microb Cell Fact] 2024 Mar 14; Vol. 23 (1), pp. 82. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Cytostatic Agents*/metabolism
Lactococcus lactis*/metabolism
Humans ; Hydrolases/metabolism ; Cell Line, Tumor ; Arginine
Czasopismo naukowe
Tytuł:
Inhibition of Multifunctional Protein p32/C1QBP Promotes Cytostatic Effects in Colon Cancer Cells by Altering Mitogenic Signaling Pathways and Promoting Mitochondrial Damage.
Autorzy:
Egusquiza-Alvarez CA; Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Moreno-Londoño AP; Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Alvarado-Ortiz E; Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Ramos-Godínez MDP; Departamento de Microscopía Electrónica, Instituto Nacional de Cancerología, Secretaría de Salud, Mexico City 14080, Mexico.
Sarabia-Sánchez MA; Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Castañeda-Patlán MC; Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Robles-Flores M; Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 27; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Cytostatic Agents*/pharmacology
Colonic Neoplasms*
Humans ; Mitogens/pharmacology ; Signal Transduction ; Mitochondrial Proteins/metabolism ; Cell Proliferation ; Carrier Proteins/metabolism
Czasopismo naukowe
Tytuł:
Protocol of the IntenSify-Trial: An open-label phase I trial of the CYP3A inhibitor cobicistat and the cytostatics gemcitabine and nab-paclitaxel in patients with advanced stage or metastatic pancreatic ductal adenocarcinoma to evaluate the combination's pharmacokinetics, safety, and efficacy.
Autorzy:
Hohmann N; Department of Medical Oncology, Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany.
Sprick MR; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Pohl M; Institute of Medical Biometry, University Hospital Heidelberg, Heidelberg, Germany.
Ahmed A; Department of Medical Oncology, Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany.
Burhenne J; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Kirchner M; Institute of Medical Biometry, University Hospital Heidelberg, Heidelberg, Germany.
Le Cornet L; NCT Trial Center, NCT, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kratzmann M; NCT Trial Center, NCT, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hajda J; Pharmacovigilance Department, Coordination Centre for Clinical Trials (KKS), Heidelberg University Hospital, Heidelberg, Germany.
Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Steindorf K; Division of Physical Activity, Prevention and Cancer, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
Delorme S; Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Schlemmer HP; Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Riethdorf S; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
van Schaik R; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
Pantel K; Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Siveke J; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK Partner Site Essen) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Seufferlein T; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Jäger D; Department of Medical Oncology, Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany.; Clinical Cooperation Unit Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Haefeli WE; Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.
Trumpp A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.
Springfeld C; Department of Medical Oncology, Heidelberg University Hospital, National Center for Tumor Diseases, Heidelberg, Germany.
Pokaż więcej
Źródło:
Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2483-2493. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Cytostatic Agents*/therapeutic use
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/pathology
Carcinoma, Pancreatic Ductal*/drug therapy
Carcinoma, Pancreatic Ductal*/pathology
Humans ; Gemcitabine ; Cytochrome P-450 CYP3A ; Cytochrome P-450 CYP3A Inhibitors ; Deoxycytidine/adverse effects ; Cobicistat ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Paclitaxel/adverse effects ; Clinical Trials, Phase I as Topic
Czasopismo naukowe
Tytuł:
The role of neuromuscular ultrasound in diagnostics of peripheral neuropathies induced by cytostatic agents or immunotherapies.
Autorzy:
Hartinger S; Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany. .; Neurooncological Center, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany. .
Hammersen J; Klinik für Innere Medizin II, Hämatologie, Internistische Onkologie und Palliativmedizin, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Deutschland.
Leistner NA; Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.
Lawson McLean A; Neurooncological Center, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.; Department of Neurosurgery, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Risse C; Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.
Senft C; Neurooncological Center, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.; Department of Neurosurgery, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Schütze S; Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Heiling B; Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.
Schwab M; Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.
Mäurer I; Department of Neurology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, 07747, Jena, Germany.; Neurooncological Center, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Nov 27; Vol. 11 (1), pp. 187. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/diagnostic imaging
Cytostatic Agents*/adverse effects
Antineoplastic Agents*/toxicity
Neurotoxicity Syndromes*
Humans ; Prospective Studies ; Immunotherapy/adverse effects
Czasopismo naukowe
Tytuł:
New Steroidal Selenides as Proapoptotic Factors.
Autorzy:
Jastrzebska I; Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.
Wawrusiewicz-Kurylonek N; Department of Clinical Genetics, Medical University of Białystok, Waszyngtona 13, 15-089 Białystok, Poland.
Grześ PA; Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.
Ratkiewicz A; Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.
Grabowska E; Doctoral School of Exact and Natural Sciences, University of Bialystok, K. Ciolkowskiego 1K, 15-245 Bialystok, Poland.
Czerniecka M; Faculty of Biology, University of Białystok, Ciołkowskiego 1J, 15-245 Białystok, Poland.
Czyżewska U; Faculty of Biology, University of Białystok, Ciołkowskiego 1J, 15-245 Białystok, Poland.
Tylicki A; Faculty of Biology, University of Białystok, Ciołkowskiego 1J, 15-245 Białystok, Poland.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Nov 10; Vol. 28 (22). Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Cytostatic Agents*/pharmacology
Humans ; HeLa Cells ; Apoptosis ; Cholesterol/metabolism
Czasopismo naukowe
Tytuł:
Characteristics of Microparticles Based on Resorbable Polyhydroxyalkanoates Loaded with Antibacterial and Cytostatic Drugs.
Autorzy:
Murueva AV; Institute of Biophysics SB RAS, Federal Research Center 'Krasnoyarsk Science Center SB RAS' (IBP SB RAS), 50/50 Akademgorodok, 660036 Krasnoyarsk, Russia.; Institute of Fundamental Biology and Biotechnology, Siberian Federal University, 79 Svobodny Pr., 660041 Krasnoyarsk, Russia.
Shershneva AM; Institute of Fundamental Biology and Biotechnology, Siberian Federal University, 79 Svobodny Pr., 660041 Krasnoyarsk, Russia.
Shishatskaya EI; Institute of Biophysics SB RAS, Federal Research Center 'Krasnoyarsk Science Center SB RAS' (IBP SB RAS), 50/50 Akademgorodok, 660036 Krasnoyarsk, Russia.; Institute of Fundamental Biology and Biotechnology, Siberian Federal University, 79 Svobodny Pr., 660041 Krasnoyarsk, Russia.; Chemistry Engineering Centre, ITMO University, Kronverkskiy Prospekt, 49A, 197101 Saint Petersburg, Russia.
Volova TG; Institute of Biophysics SB RAS, Federal Research Center 'Krasnoyarsk Science Center SB RAS' (IBP SB RAS), 50/50 Akademgorodok, 660036 Krasnoyarsk, Russia.; Institute of Fundamental Biology and Biotechnology, Siberian Federal University, 79 Svobodny Pr., 660041 Krasnoyarsk, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 07; Vol. 24 (19). Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Polyhydroxyalkanoates*
Cytostatic Agents*
Escherichia coli ; Drug Delivery Systems ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/chemistry ; Particle Size
Czasopismo naukowe
Tytuł:
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors.
Autorzy:
Elshazly AM; Department of Pharmacology and Toxicology, Massey Cancer Center, Virginia Commonwealth University, 401 College St., Richmond, VA 23298, USA.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.
Gewirtz DA; Department of Pharmacology and Toxicology, Massey Cancer Center, Virginia Commonwealth University, 401 College St., Richmond, VA 23298, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 11; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 11.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Cytostatic Agents*
Antineoplastic Agents*/pharmacology
Animals ; Nuclear Proteins ; Transcription Factors ; Autophagy
Czasopismo naukowe
Tytuł:
Identification of Bacterial Metabolites Modulating Breast Cancer Cell Proliferation and Epithelial-Mesenchymal Transition.
Autorzy:
Ujlaki G; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Kovács T; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Vida A; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Kókai E; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Rauch B; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Schwarcz S; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Mikó E; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Janka E; Department of Dermatology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Sipos A; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Hegedűs C; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Uray K; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Nagy P; Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Bai P; Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.; MTA-DE Lendület Laboratory of Cellular Metabolism, 4032 Debrecen, Hungary.; Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.; ELKH-DE Cell Biology and Signaling Research Group ELKH, 4032 Debrecen, Hungary.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Aug 05; Vol. 28 (15). Date of Electronic Publication: 2023 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Breast Neoplasms*/metabolism
Cytostatic Agents*/pharmacology
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Humans ; Animals ; Mice ; Female ; Epithelial-Mesenchymal Transition ; Butyric Acid/pharmacology ; Cell Line, Tumor ; Cell Proliferation
Czasopismo naukowe
Tytuł:
Functionalization of Octacalcium Phosphate Bone Graft with Cisplatin and Zoledronic Acid: Physicochemical and Bioactive Properties.
Autorzy:
Kuvshinova EA; P.A. Herzen Moscow Research Oncology Institute, Branch of FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.
Petrakova NV; A.A. Baikov Institute of Metallurgy and Materials Science RAS, Leninsky Avenue 49, 119334 Moscow, Russia.
Nikitina YO; A.A. Baikov Institute of Metallurgy and Materials Science RAS, Leninsky Avenue 49, 119334 Moscow, Russia.
Sviridova IK; P.A. Herzen Moscow Research Oncology Institute, Branch of FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.
Akhmedova SA; P.A. Herzen Moscow Research Oncology Institute, Branch of FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.
Kirsanova VA; P.A. Herzen Moscow Research Oncology Institute, Branch of FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.
Karalkin PA; P.A. Herzen Moscow Research Oncology Institute, Branch of FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.; L.L. Levshin Institute of Cluster Oncology, I.M. Sechenov First Moscow State Medical University, Trubetskaya 8-2, 119991 Moscow, Russia.
Komlev VS; A.A. Baikov Institute of Metallurgy and Materials Science RAS, Leninsky Avenue 49, 119334 Moscow, Russia.
Sergeeva NS; P.A. Herzen Moscow Research Oncology Institute, Branch of FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.
Kaprin AD; FSBI National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, 2nd Botkinsky Pass. 3, 125284 Moscow, Russia.; Department of Urology and Operative Nephrology, Peoples' Friendship University of Russia, Miklukho-Maklay Str., 6, 117198 Moscow, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 19; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 19.
Typ publikacji:
Journal Article
MeSH Terms:
Cisplatin*/pharmacology
Cytostatic Agents*
Male ; Animals ; Zoledronic Acid/pharmacology ; Calcium Phosphates/chemistry ; Bone Regeneration
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies